Abstract

Dengue virus (DENV) is the most prevalent mosquito-borne virus causing human disease. Of the 4 DENV serotypes, epidemiological data suggest that DENV-2 secondary infections are associated with more severe disease than DENV-4 infections. Mass cytometry by time-of-flight (CyTOF) was used to dissect immune changes induced by DENV-2 and DENV-4 in human DCs, the initial targets of primary infections that likely affect infection outcomes. Strikingly, DENV-4 replication peaked earlier and promoted stronger innate immune responses, with increased expression of DC activation and migration markers and increased cytokine production, compared with DENV-2. In addition, infected DCs produced higher levels of inflammatory cytokines compared with bystander DCs, which mainly produced IFN-induced cytokines. These high-dimensional analyses during DENV-2 and DENV-4 infections revealed distinct viral signatures marked by different replication strategies and antiviral innate immune induction in DCs, which may result in different viral fitness, transmission, and pathogenesis.

Highlights

  • Dengue virus (DENV) is the most prevalent mosquito-borne virus causing disease in humans [1], with an estimated 390 million annual infections worldwide, of which 96 million manifest with clinical symptoms [2]

  • Using cytometry by time-of-flight (CyTOF) analysis to measure intracellular DENV structural and nonstructural proteins and titration of extracellular infectious DENV particles, we found that DENV-2 peak infection occurred at 48 hours after infection, whereas DENV-4 infection peaked at 24 hpi and was significantly diminished by 72 hpi (Figure 1, A–D)

  • Even though DENV-2 infected a smaller percentage of cells compared with DENV-4, those DCs infected with DENV-2 showed significantly higher levels of DENV nonstructural 3 (NS3) protein (Figure 1C) at 48 and 72 hpi compared with the DCs infected with DENV-4

Read more

Summary

Introduction

Dengue virus (DENV) is the most prevalent mosquito-borne virus causing disease in humans [1], with an estimated 390 million annual infections worldwide, of which 96 million manifest with clinical symptoms [2]. Dengue disease may present as a nonspecific febrile illness or as a more severe infection marked by hemorrhage or circulatory failure [3, 4]. DENV is a flavivirus that exists as 4 distinct serotypes (DENV-1– DENV-4) and is transmitted by Aedes mosquitoes [5]. At the amino acid level, the 4 DENV serotypes share limited similarity among serotypes (about 60%–75%) but about 97% similarity within a given serotype [6]. Epidemiological studies have reported differences between serotypes with regard to disease severity. DENV-2 secondary infections have been associated with more severe disease, while DENV-4 infections have been correlated with more mild disease [7,8,9,10,11,12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call